pharmaphorum2d
Artificial Intelligence for better antibody drugs: ready for prime time?
AI for accelerated antibody discovery Traditionally ... In addition to its proprietary generative AI, the company has its own automation platform to rapidly synthesise and test antibodies in ...
Business Wire4d
ImmunoPrecise Antibodies Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles Innovation
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) today announced the launch of its AI-powered pipeline of both optimized and new therapeutics, a system set ...
Yahoo Finance4d
ImmunoPrecise Antibodies Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles Innovation
"Our AI-powered pipeline represents a major leap forward for IPA," said Dr. Jennifer Bath, CEO of ImmunoPrecise Antibodies. "By harnessing AI and rethinking drug discovery from the ground up ...
ImmunoPrecise Antibodies Ltd. (IPA) Launches AI-Powered Drug Discovery Pipeline, Revolutionizing Therapeutic Development with LENSai™ Platform
We recently compiled a list of the 10 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...
ImmunoPrecise Antibodies realigns pipeline strategy, AI-powered pipeline
ImmunoPrecise Antibodies (IPA) announced the launch of its AI-powered pipeline of both optimized and new therapeutics. By combining advanced ...